Personal information

Emails & domains

Verified email domains

Other IDs

SciProfiles: 1484007

Activities

Collapse all

Employment (1)

Medical University of Vienna: Vienna, AT

2013-10-03 to present | Deputy Head (Division of Nuclear Medicine)
Employment
Source: Self-asserted source
Alexander Haug

Works (50 of 137)

Items per page:
Page 1 of 3

Direct Patlak Reconstruction of [<sup>68</sup>Ga]Ga-PSMA PET for the Evaluation of Primary Prostate Cancer Prior Total Prostatectomy: Results of a Pilot Study

International Journal of Molecular Sciences
2023-09 | Journal article | Author
DOI: 10.3390/ijms241813677
Contributors: Sazan Rasul; Barbara Katharina Geist; Holger Einspieler; Harun Fajkovic; Shahrokh F. Shariat; Stefan Schmitl; Markus Mitterhauser; Rainer Bartosch; Werner Langsteger; Pascal Baltzer et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

A Prognostic Risk Score for Prostate Cancer Based on PSMA PET–derived Organ-specific Tumor Volumes

Radiology
2023-05-01 | Journal article
DOI: 10.1148/radiol.222010
Contributors: Robert Seifert; Sazan Rasul; Konstantin Seitzer; Maria Eveslage; Laya Rahbar Nikoukar; Katharina Kessel; Michael Schäfers; Josef Yu; Alexander R. Haug; Marcus Hacker et al.
Source: check_circle
Crossref

Evaluation of Intestinal Fibrosis with 68Ga-FAPI PET/MR Enterography in Crohn Disease

Radiology
2023-05-01 | Journal article
DOI: 10.1148/radiol.222389
Contributors: Martina Scharitzer; Andrea Macher-Beer; Thomas Mang; Lukas W. Unger; Alexander Haug; Walter Reinisch; Michael Weber; Thomas Nakuz; Lukas Nics; Marcus Hacker et al.
Source: check_circle
Crossref

Data from In Human Visualization of Ibrutinib-Induced CLL Compartment Shift

2023-04-04 | Preprint
DOI: 10.1158/2326-6066.c.6550162
Contributors: Marius E. Mayerhoefer; Alexander Haug; Ulrich Jäger; Verena Pichler; Sarah Pfaff; Hans-Jürgen Wester; Marcus Hacker; Lukas Kazianka; Philipp B. Staber
Source: check_circle
Crossref

Data from In Human Visualization of Ibrutinib-Induced CLL Compartment Shift

2023-04-04 | Preprint
DOI: 10.1158/2326-6066.c.6550162.v1
Contributors: Marius E. Mayerhoefer; Alexander Haug; Ulrich Jäger; Verena Pichler; Sarah Pfaff; Hans-Jürgen Wester; Marcus Hacker; Lukas Kazianka; Philipp B. Staber
Source: check_circle
Crossref

Supplementary Figures and Legends from In Human Visualization of Ibrutinib-Induced CLL Compartment Shift

2023-04-04 | Preprint
DOI: 10.1158/2326-6066.22543171
Contributors: Marius E. Mayerhoefer; Alexander Haug; Ulrich Jäger; Verena Pichler; Sarah Pfaff; Hans-Jürgen Wester; Marcus Hacker; Lukas Kazianka; Philipp B. Staber
Source: check_circle
Crossref

Supplementary Figures and Legends from In Human Visualization of Ibrutinib-Induced CLL Compartment Shift

2023-04-04 | Preprint
DOI: 10.1158/2326-6066.22543171.v1
Contributors: Marius E. Mayerhoefer; Alexander Haug; Ulrich Jäger; Verena Pichler; Sarah Pfaff; Hans-Jürgen Wester; Marcus Hacker; Lukas Kazianka; Philipp B. Staber
Source: check_circle
Crossref

Supplementary Table 1 from In Human Visualization of Ibrutinib-Induced CLL Compartment Shift

2023-04-04 | Preprint
DOI: 10.1158/2326-6066.22543168
Contributors: Marius E. Mayerhoefer; Alexander Haug; Ulrich Jäger; Verena Pichler; Sarah Pfaff; Hans-Jürgen Wester; Marcus Hacker; Lukas Kazianka; Philipp B. Staber
Source: check_circle
Crossref

Supplementary Table 1 from In Human Visualization of Ibrutinib-Induced CLL Compartment Shift

2023-04-04 | Preprint
DOI: 10.1158/2326-6066.22543168.v1
Contributors: Marius E. Mayerhoefer; Alexander Haug; Ulrich Jäger; Verena Pichler; Sarah Pfaff; Hans-Jürgen Wester; Marcus Hacker; Lukas Kazianka; Philipp B. Staber
Source: check_circle
Crossref

Supplementary Table 2 from In Human Visualization of Ibrutinib-Induced CLL Compartment Shift

2023-04-04 | Preprint
DOI: 10.1158/2326-6066.22543165
Contributors: Marius E. Mayerhoefer; Alexander Haug; Ulrich Jäger; Verena Pichler; Sarah Pfaff; Hans-Jürgen Wester; Marcus Hacker; Lukas Kazianka; Philipp B. Staber
Source: check_circle
Crossref

Supplementary Table 2 from In Human Visualization of Ibrutinib-Induced CLL Compartment Shift

2023-04-04 | Preprint
DOI: 10.1158/2326-6066.22543165.v1
Contributors: Marius E. Mayerhoefer; Alexander Haug; Ulrich Jäger; Verena Pichler; Sarah Pfaff; Hans-Jürgen Wester; Marcus Hacker; Lukas Kazianka; Philipp B. Staber
Source: check_circle
Crossref

Supplementary Table 3 from In Human Visualization of Ibrutinib-Induced CLL Compartment Shift

2023-04-04 | Preprint
DOI: 10.1158/2326-6066.22543162
Contributors: Marius E. Mayerhoefer; Alexander Haug; Ulrich Jäger; Verena Pichler; Sarah Pfaff; Hans-Jürgen Wester; Marcus Hacker; Lukas Kazianka; Philipp B. Staber
Source: check_circle
Crossref

Supplementary Table 3 from In Human Visualization of Ibrutinib-Induced CLL Compartment Shift

2023-04-04 | Preprint
DOI: 10.1158/2326-6066.22543162.v1
Contributors: Marius E. Mayerhoefer; Alexander Haug; Ulrich Jäger; Verena Pichler; Sarah Pfaff; Hans-Jürgen Wester; Marcus Hacker; Lukas Kazianka; Philipp B. Staber
Source: check_circle
Crossref

Evaluation of the Efficacy of a Combined Treatment Using the mTOR-Inhibitor Everolimus and [177Lu]Lu-DOTA-TATE in Nude CD1 Mice with SSTR-Expressing Pancreatic AR42J Xenograft Tumors

Biomedicines
2022-12-01 | Journal article
DOI: 10.3390/biomedicines10123102
Contributors: Johannes Zellmer; Hsi-Yu Yen; Lena Kaiser; Franz Josef Gildehaus; Guido Böning; Katja Steiger; Marcus Hacker; Peter Bartenstein; Andrei Todica; Alexander R. Haug et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

CAM-Xenograft Model Provides Preclinical Evidence for the Applicability of [68Ga]Ga-Pentixafor in CRC Imaging

Cancers
2022-11-11 | Journal article
DOI: 10.3390/cancers14225549
Contributors: Katarína Benčurová; Joachim Friske; Maximilian Anderla; Manuela Mayrhofer; Thomas Wanek; Lukas Nics; Gerda Egger; Thomas H. Helbich; Marcus Hacker; Alexander Haug et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Clinical Applications of PSMA PET Examination in Patients with Prostate Cancer

Cancers
2022-08-02 | Journal article
DOI: 10.3390/cancers14153768
Contributors: Sazan Rasul; Alexander R. Haug
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Imaging Inflammation in Atherosclerosis with CXCR4-Directed [68Ga]PentixaFor PET/MRI—Compared with [18F]FDG PET/MRI

Life
2022-07-12 | Journal article
DOI: 10.3390/life12071039
Contributors: Xia Lu; Raffaella Calabretta; Wolfgang Wadsak; Alexander Haug; Marius Mayerhöfer; Markus Raderer; Xiaoli Zhang; Jingle Li; Marcus Hacker; Xiang Li
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Analysis of Cross-Combinations of Feature Selection and Machine-Learning Classification Methods Based on [18F]F-FDG PET/CT Radiomic Features for Metabolic Response Prediction of Metastatic Breast Cancer Lesions

Cancers
2022-06-14 | Journal article
DOI: 10.3390/cancers14122922
Contributors: Ober Van Gómez; Joaquin L. Herraiz; José Manuel Udías; Alexander Haug; Laszlo Papp; Dania Cioni; Emanuele Neri
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Immune Checkpoint Inhibitor Therapy Induces Inflammatory Activity in the Large Arteries of Lymphoma Patients under 50 Years of Age

Biology
2021-11-19 | Journal article
DOI: 10.3390/biology10111206
Contributors: Raffaella Calabretta; Philipp B. Staber; Christoph Kornauth; Xia Lu; Patrick Binder; Verena Pichler; Markus Mitterhauser; Alexander Haug; Xiang Li; Marcus Hacker
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Renal and Salivary Gland Functions after Three Cycles of PSMA-617 Therapy Every Four Weeks in Patients with Metastatic Castration-Resistant Prostate Cancer

Current Oncology
2021-09 | Journal article | Author
DOI: 10.3390/curroncol28050315
Contributors: Tim Wollenweber; Lucia Zisser; Elisabeth Kretschmer-Chott; Michael Weber; Bernhard Grubmüller; Gero Kramer; Shahrokh F. Shariat; Markus Mitterhauser; Stefan Schmitl; Chrysoula Vraka et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Response and Toxicity to the Second Course of 3 Cycles of <sup>177</sup>Lu-PSMA Therapy Every 4 Weeks in Patients with Metastatic Castration-Resistant Prostate Cancer

Cancers
2021-05 | Journal article | Author
DOI: 10.3390/cancers13102489
Contributors: Sazan Rasul; Tim Wollenweber; Lucia Zisser; Elisabeth Kretschmer-Chott; Bernhard Grubmüller; Gero Kramer; Shahrokh F. Shariat; Harald Eidherr; Markus Mitterhauser; Chrysoula Vraka et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Breast Tumor Characterization Using [18F]FDG-PET/CT Imaging Combined with Data Preprocessing and Radiomics

Cancers
2021-03-12 | Journal article
DOI: 10.3390/cancers13061249
Contributors: Denis Krajnc; Laszlo Papp; Thomas S. Nakuz; Heinrich F. Magometschnigg; Marko Grahovac; Clemens P. Spielvogel; Boglarka Ecsedi; Zsuzsanna Bago-Horvath; Alexander Haug; Georgios Karanikas et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Immune Checkpoint Inhibitor Therapy Induces Inflammatory Activity in Large Arteries

Circulation
2020-12-15 | Journal article
DOI: 10.1161/CIRCULATIONAHA.120.048708
Contributors: Raffaella Calabretta; Christoph Hoeller; Verena Pichler; Markus Mitterhauser; Georgios Karanikas; Alexander Haug; Xiang Li; Marcus Hacker
Source: check_circle
Crossref

In Human Visualization of Ibrutinib-Induced CLL Compartment Shift

Cancer Immunology Research
2020-08-01 | Journal article
DOI: 10.1158/2326-6066.CIR-19-0880
Contributors: Marius E. Mayerhoefer; Alexander Haug; Ulrich Jäger; Verena Pichler; Sarah Pfaff; Hans-Jürgen Wester; Marcus Hacker; Lukas Kazianka; Philipp B. Staber
Source: check_circle
Crossref

Is there a reliable size cut-off for splenic involvement in lymphoma? A [18F]FDG-PET controlled study.

PloS one
2019-03 | Journal article
DOI: 10.1371/journal.pone.0213551
PMID: 30849131
Contributors: Berzaczy D; Haug AR; Raderer M; Kiesewetter B; Berzaczy G; Weber M; Mayerhoefer ME
Source: Self-asserted source
Alexander Haug via Europe PubMed Central

Dynamic [18F]FET-PET/MRI using standard MRI-based attenuation correction methods.

European radiology
2019-01 | Journal article
DOI: 10.1007/s00330-018-5942-9
PMID: 30635757
Contributors: Rausch I; Zitterl A; Berroterán-Infante N; Rischka L; Prayer D; Fenchel M; Sareshgi RA; Haug AR; Hacker M; Beyer T et al.
Source: Self-asserted source
Alexander Haug via Europe PubMed Central

[11C]acetate PET as a tool for diagnosis of liver steatosis

Abdominal radiology (New York)
2018 | Journal article
DOI: 10.1007/s00261-018-1558-4
Source: Self-asserted source
Alexander Haug
grade
Preferred source (of 2)‎

[18F]FDG-PET/CT and MRI for initial pelvic lymph node staging in patients with cervical carcinoma: The potential usefulness of [18F]FDG-PET/MRI

Oncology letters
2018 | Journal article
DOI: 10.3892/ol.2018.7775
Source: Self-asserted source
Alexander Haug

[68Ga]Ga-Pentixafor PET/MRI for CXCR4 Imaging of Chronic Lymphocytic Leukemia: Preliminary Results

Investigative radiology
2018 | Journal article
DOI: 10.1097/rli.0000000000000469
Source: Self-asserted source
Alexander Haug

[68Ga]Pentixafor-PET/MRI for the detection of Chemokine receptor 4 expression in atherosclerotic plaques

European journal of nuclear medicine and molecular imaging
2018 | Journal article
DOI: 10.1007/s00259-017-3831-0
Source: Self-asserted source
Alexander Haug

[Practice guideline neuroendocrine tumors - AWMF-Reg. 021-27]

Zeitschrift fur Gastroenterologie
2018 | Journal article
DOI: 10.1055/a-0604-2924
Source: Self-asserted source
Alexander Haug

A Diagnostic Algorithm That Combines Quantitative 18F-FDG PET Parameters and Contrast-Enhanced CT Improves Posttherapeutic Locoregional Restaging and Prognostication of Survival in Patients With Esophageal Cancer

Clinical nuclear medicine
2018 | Journal article
DOI: 10.1097/rlu.0000000000002366
Source: Self-asserted source
Alexander Haug

Analysis of hematological parameters as prognostic markers for toxicity and survival of 223Radium treatment

Oncotarget
2018 | Journal article
DOI: 10.18632/oncotarget.24610
Source: Self-asserted source
Alexander Haug

Appearances are often deceptive

Nuklearmedizin. Nuclear medicine
2018 | Journal article
DOI: 10.1055/s-0038-1668502
Source: Self-asserted source
Alexander Haug

Clinical Value of 18F-FDOPA PET/CT With Contrast Enhancement and Without Carbidopa Premedication in Patients with Insulinoma

Anticancer research
2018 | Journal article
DOI: 10.21873/anticanres.12229
Source: Self-asserted source
Alexander Haug

Combined [18F]-Fluoroethylcholine PET/CT and 99mTc-Macroaggregated Albumin SPECT/CT Predict Survival in Patients With Intermediate-Stage Hepatocellular Carcinoma

Clinical nuclear medicine
2018 | Journal article
DOI: 10.1097/rlu.0000000000002092
Source: Self-asserted source
Alexander Haug

Current status of theranostics in prostate cancer

European journal of nuclear medicine and molecular imaging
2018 | Journal article
DOI: 10.1007/s00259-017-3882-2
Source: Self-asserted source
Alexander Haug

Oral Ondansetron Offers Effective Antidiarrheal Activity for Carcinoid Syndrome Refractory to Somatostatin Analogs

The oncologist
2018 | Journal article
DOI: 10.1634/theoncologist.2018-0191
Source: Self-asserted source
Alexander Haug

PSMA Ligand PET/MRI for Primary Prostate Cancer: Staging Performance and Clinical Impact

Clinical cancer research : an official journal of the American Association for Cancer Research
2018 | Journal article
DOI: 10.1158/1078-0432.ccr-18-0768
Source: Self-asserted source
Alexander Haug
grade
Preferred source (of 2)‎

Reduced task durations in functional PET imaging with [18F]FDG approaching that of functional MRI

NeuroImage
2018 | Journal article
DOI: 10.1016/j.neuroimage.2018.06.079
Source: Self-asserted source
Alexander Haug

The prognostic value of [123I]-vascular endothelial growth factor ([123I]-VEGF) in glioma

European journal of nuclear medicine and molecular imaging
2018 | Journal article
DOI: 10.1007/s00259-018-4088-y
Source: Self-asserted source
Alexander Haug

Ultra-early response assessment in lymphoma treatment: [18F]FDG PET/MR captures changes in glucose metabolism and cell density within the first 72 hours of treatment

European journal of nuclear medicine and molecular imaging
2018 | Journal article
DOI: 10.1007/s00259-018-3937-z
Source: Self-asserted source
Alexander Haug

Visual and semiquantitative 11C-methionine PET: an independent prognostic factor for survival of newly diagnosed and treatment-naïve gliomas

Neuro-oncology
2018 | Journal article
DOI: 10.1093/neuonc/nox177
Source: Self-asserted source
Alexander Haug

Response assessment using 68Ga-PSMA ligand PET in patients undergoing 177Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancer.

European journal of nuclear medicine and molecular imaging
2018-12 | Journal article
DOI: 10.1007/s00259-018-4236-4
PMID: 30569186
Contributors: Grubmüller B; Senn D; Kramer G; Baltzer P; D'Andrea D; Grubmüller KH; Mitterhauser M; Eidherr H; Haug AR; Wadsak W et al.
Source: Self-asserted source
Alexander Haug via Europe PubMed Central

[Selective intraarterial radiotherapy (SIRT) of malignant liver tumors]

Nuklearmedizin. Nuclear medicine
2017 | Journal article
DOI: 10.3413/nukmed-2017-05-0001
Source: Self-asserted source
Alexander Haug

Cold-Induced Brown Adipose Tissue Activity Alters Plasma Fatty Acids and Improves Glucose Metabolism in Men

The Journal of clinical endocrinology and metabolism
2017 | Journal article
DOI: 10.1210/jc.2017-01250
Source: Self-asserted source
Alexander Haug

Does elevated glucose metabolism correlate with higher cell density in Neurofibromatosis type 1 associated peripheral nerve sheath tumors?

PloS one
2017 | Journal article
DOI: 10.1371/journal.pone.0189093
Source: Self-asserted source
Alexander Haug

Effectiveness of Reduced Radioiodine Activity for Thyroid Remnant Ablation after Total Thyroidectomy in Patients with Low to Intermediate Risk Differentiated Thyroid Carcinoma

Nuklearmedizin. Nuclear medicine
2017 | Journal article
DOI: 10.3413/nukmed-0922-17-08
Source: Self-asserted source
Alexander Haug

Efficacy of peptide receptor radionuclide therapy with 177Lu-octreotate in metastatic pulmonary neuroendocrine tumors: a dual-centre analysis

American journal of nuclear medicine and molecular imaging
2017 | Journal article
Source: Self-asserted source
Alexander Haug

Imaging of primary liver tumors with positron-emission tomography

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...
2017 | Journal article
DOI: 10.23736/s1824-4785.17.02994-6
Source: Self-asserted source
Alexander Haug
Items per page:
Page 1 of 3

Peer review (7 reviews for 3 publications/grants)

Review activity for EJNMMI research. (2)
Review activity for European journal of nuclear medicine and molecular imaging. (4)
Review activity for Molecular imaging and biology (1)
How many people are using ORCID?